Palabras clave
Diabetes Mellitus
insulina
secreción de Insulina
insulina
secreción de Insulina
Cómo citar
Reyes Leal, B., Bernal Hernández, E., Castro, A., & Guardiola, O. (2018). Estudios sobre la Secreción de Insulina. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, -9(1), 5–21. https://doi.org/10.53853/encr.-9.1.208
Resumen
Fragmento
INTRODUCCION
El problema de la Diabetes Mellitus en nuestro país como en el resto del mundo es sin lugar a dudas el más importante problema de salud que debe afrontar el médico en el momento actual.
No se trata simplemente de pensar en el diabético clásico con su cortejo de comas, insulina, amputaciones o problemas visuales; se trata también de la etiologia del infarto del miocardio y la obesidad muy posiblemente relacionadas con lo que llamamos Diabetes y que constituyen las mayores causas de mortalidad en esta parte del siglo.
Citas
1. ARNOULD Y., BELLENS R. FRANKSON J.R.M. and CONARD V. Insulin response and Glucose c14 disappearance rate during the glucose tolerance test in the unanesthetized dog. METABOLISM 12,1122. 1963.
2. McINTYRE N., HOLDSWORTH C.D. and TURNER. D.S. Intestinal factors in the control of Insulin secretion. J. CLIN. ENDOCRINOL. 24. 1317, 1965.
3. DUPRE. J. and intestinal hormone affactin glucose disposal in man. LANCET Vol II, 672, 1964.
4. UNGER. R. H. - The effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon secretion in anesthetized dogs. J. CLIN. INVEST. 46. 630 1967.
5. SOLS A. Hexokinase and Glucokinase. in Control of Glycogen Metabolism. Ciba Foundation Symposium. 301. 1964.
6. GONZALES O.C. Portography, a preliminary of a new technique via umbilical vein. CLIN, PROC. CHILD. HOSP, WASH. 15,120. 1959.
7. HALES C.N., RANDLE P.J. Inmunoassay of Insulin with Insulin Antibody precipitate. BIOCHEM. J., 88, 137) 1963.
8. BEIGELMAN P.M. Bio-assay for Insulin-like-activity utilizing glucose uptake by adipose tissue. METABOLISM. 9, 580. 1960.
9. POWER L. REYES-LEAL B. and CONN J.W. Serum Insulin-like-activity in genetic and experimental Diabetes Mellitus. METABOLISM. No. 13,1297, 4.
10. YALOW. R.S. and BERSON S.A. Inmunoassay of endogenous plasma Insulin in man. J. CIN. INVEST. 39,1157, 1960.
11. GRODSKY G.M. and FORSHAM. P.H. and inmunochemical assay of total extractable Insulin in man. J. CLIN. INVEST. 36,1070, 1960.
12. MORGAN C.R. and LAZAROW A. Immunoassay of Insulin using capture and degradation of Insulin 1131 by the cyclically perfused ratliver. ANN. N. Y. ACAD. SCI.82/2,329, 1959.
13. MORTIMER G.E. and TIETZE. F. Studies on the mechanism of capture and degradation of Insulin 1131 by the cyclically perfused rat liver. ANN. N.Y. ACAD. SCI. 82/2, 329, 1959.
14. CURRY D.L. BENNETT L.L. and GRODSKY G.M. Dynamics of Insulin secretion by the perfused rat pancreas. ENDOCRINOLOGY 83,572, 1968.
15. BLACKARD W.G. AND NELSON N.C. Portal and peripheral vein inmunoreactive Insulin concentration before and after glucose infusión. DIABETES 19, 302, 1970.
16. CRISHOLM. D.J., YOUNG J.D. and LAZARUS L. the gastrointestinal stimulus to Insulin release. I Scretin. J. CLIN INVEST. 48.1453, 1969.
17. REAVEN G.M., SHEN S.W., SILVERS A. and FARQUHAR. J.W. Is there a delay in the plasma Insulin of patients with chemical Diabetes Mellitus. DIABETES 20, 416, 1971.
2. McINTYRE N., HOLDSWORTH C.D. and TURNER. D.S. Intestinal factors in the control of Insulin secretion. J. CLIN. ENDOCRINOL. 24. 1317, 1965.
3. DUPRE. J. and intestinal hormone affactin glucose disposal in man. LANCET Vol II, 672, 1964.
4. UNGER. R. H. - The effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon secretion in anesthetized dogs. J. CLIN. INVEST. 46. 630 1967.
5. SOLS A. Hexokinase and Glucokinase. in Control of Glycogen Metabolism. Ciba Foundation Symposium. 301. 1964.
6. GONZALES O.C. Portography, a preliminary of a new technique via umbilical vein. CLIN, PROC. CHILD. HOSP, WASH. 15,120. 1959.
7. HALES C.N., RANDLE P.J. Inmunoassay of Insulin with Insulin Antibody precipitate. BIOCHEM. J., 88, 137) 1963.
8. BEIGELMAN P.M. Bio-assay for Insulin-like-activity utilizing glucose uptake by adipose tissue. METABOLISM. 9, 580. 1960.
9. POWER L. REYES-LEAL B. and CONN J.W. Serum Insulin-like-activity in genetic and experimental Diabetes Mellitus. METABOLISM. No. 13,1297, 4.
10. YALOW. R.S. and BERSON S.A. Inmunoassay of endogenous plasma Insulin in man. J. CIN. INVEST. 39,1157, 1960.
11. GRODSKY G.M. and FORSHAM. P.H. and inmunochemical assay of total extractable Insulin in man. J. CLIN. INVEST. 36,1070, 1960.
12. MORGAN C.R. and LAZAROW A. Immunoassay of Insulin using capture and degradation of Insulin 1131 by the cyclically perfused ratliver. ANN. N. Y. ACAD. SCI.82/2,329, 1959.
13. MORTIMER G.E. and TIETZE. F. Studies on the mechanism of capture and degradation of Insulin 1131 by the cyclically perfused rat liver. ANN. N.Y. ACAD. SCI. 82/2, 329, 1959.
14. CURRY D.L. BENNETT L.L. and GRODSKY G.M. Dynamics of Insulin secretion by the perfused rat pancreas. ENDOCRINOLOGY 83,572, 1968.
15. BLACKARD W.G. AND NELSON N.C. Portal and peripheral vein inmunoreactive Insulin concentration before and after glucose infusión. DIABETES 19, 302, 1970.
16. CRISHOLM. D.J., YOUNG J.D. and LAZARUS L. the gastrointestinal stimulus to Insulin release. I Scretin. J. CLIN INVEST. 48.1453, 1969.
17. REAVEN G.M., SHEN S.W., SILVERS A. and FARQUHAR. J.W. Is there a delay in the plasma Insulin of patients with chemical Diabetes Mellitus. DIABETES 20, 416, 1971.
Los autores deben declarar revisión, validación y aprobación para publicación del manuscrito, además de la cesión de los derechos de publicación, mediante un documento que debe ser enviado antes de la aparición del escrito. Puede consultar una copia del documento aquí